Aβ42 oligomers selectively disrupt neuronal calcium release

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 877-885

  Lazzari, Cristian ^a   Kipanyula, Maulilio J ^a,c   Agostini, Mario ^a   Pozzan, Tullio ^a,b   Fasolato, Cristina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c SOKOINE UNIVERSITY OF AGRICULTURE   (Tanzania)

Author keywords

Alzheimer's disease; A 42 monomers; A 42 oligomers; Calcium stores; Endoplasmic reticulum; ERD4 cameleon; Fura 2; Mouse cortical neurons

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CAFFEINE; CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE; METABOTROPIC RECEPTOR 5; MONOMER; OLIGOMER; POTASSIUM CHLORIDE; RYANODINE RECEPTOR; TETANUS TOXIN; TETRODOTOXIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); CALCIUM; FURA 2; GRM5 PROTEIN, MOUSE; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSOL; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; EXOCYTOSIS; MOUSE; NERVE CELL; NEUROTOXICITY; NONHUMAN; ALZHEIMER DISEASE; ANIMAL; C57BL MOUSE; CELL CULTURE; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; POLYMERIZATION; RAT; STRUCTURE ACTIVITY RELATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM; CELLS, CULTURED; CYTOSOL; ENDOPLASMIC RETICULUM; FURA-2; HUMANS; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; NEURONS; PEPTIDE FRAGMENTS; POLYMERIZATION; POTASSIUM CHLORIDE; RATS; RECEPTOR, METABOTROPIC GLUTAMATE 5; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84922777572     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.10.020     Document Type: Article

References (67)

1. 2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 2010, 47:264-272.
2. Arispe N., Diaz J., Durell S.R., Shafrir Y., Guy H.R. Polyhistidine peptide inhibitor of the Aβ calcium channel potently blocks the Aβ-induced calcium response in cells. Theoretical modeling suggests a cooperative binding process. Biochemistry 2010, 49:7847-7853.
3. Berman D.E., Dall'Armi C., Voronov S.V., McIntire L.B., Zhang H., Moore A.Z., et al. Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat. Neurosci. 2008, 11:547-554.
4. Berridge M.J. Calcium regulation of neural rhythms, memory and Alzheimer's disease. J.Physiol. 2014, 592(Pt 2):281-293.
5. Bojarski L., Herms J., Kuznicki J. Calcium dysregulation in Alzheimer's disease. Neurochem. Int. 2008, 52:621-633.
6. Bruno A.M., Huang J.Y., Bennett D.A., Marr R.A., Hastings M.L., Stutzmann G.E. Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2012, 33:1001.e1-1001.e6.
7. Busche M.A., Chen X., Henning H.A., Reichwald J., Staufenbiel M., Sakmann B., Konnerth A. Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:8740-8745.
8. Busche M.A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K.H., Haass C., Staufenbiel M., Konnerth A., Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008, 321:1686-1689.
9. Camandola S., Mattson M.P. Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim. Biophys. Acta 2011, 1813:965-973.
10. 2+ channel function as an early preventative strategy for Alzheimer's disease. PLoS One 2012, 7:e52056.
11. Chakroborty S., Goussakov I., Miller M.B., Stutzmann G.E. Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. J.Neurosci. 2009, 29:9458-9470.
12. Chakroborty S., Stutzmann G.E. Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures. Eur. J. Pharmacol. 2014, 739:83-95.
13. Chow V.W., Mattson M.P., Wong P.C., Gleichmann M. An overview of APP processing enzymes and products. Neuromolecular. Med. 2010, 12:1-12.
14. Costa R.O., Ferreiro E., Martins I., Santana I., Cardoso S.M., Oliveira C.R., Pereira C.M. Amyloid β-induced ER stress is enhanced under mitochondrial dysfunction conditions. Neurobiol. Aging 2012, 33:824.e5-824.e16.
15. D'Amelio M., Cavallucci V., Middei S., Marchetti C., Pacioni S., Ferri A., et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat. Neurosci. 2011, 14:69-76.
16. De Felice F.G., Velasco P.T., Lambert M.P., Viola K., Fernandez S.J., Ferreira S.T., Klein W.L. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J.Biol. Chem. 2007, 282:11590-11601.
17. 2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate. J.Neurosci. 2013, 33:3824-3833.
18. Demuro A., Parker I., Stutzmann G.E. Calcium signaling and amyloid toxicity in Alzheimer's disease. J.Biol. Chem. 2010, 285:12463-12468.
19. 2+ imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology. J.Cell. Biol. 2011, 195:515-524.
20. Deshpande A., Kawai H., Metherate R., Glabe C.G., Busciglio J. Arole for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. J.Neurosci. 2009, 29:4004-4015.
21. Dolev I., Fogel H., Milshtein H., Berdichevsky Y., Lipstein N., Brose N., Gazit N., Slutsky I. Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change. Nat. Neurosci. 2013, 16:587-595.
22. 2+ accumulation, storage and release. J.Biol. Chem. 1991, 267:20159-20167.
23. Ferreira S.T., Klein W.L. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol. Learn. Mem. 2011, 96:529-543.
24. 2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiol. Dis. 2005, 18:638-648.
25. 2+ influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice. J.Neurosci. 2010, 30:12128-12137.
26. Green K.N., LaFerla F.M. Linking calcium to Abeta and Alzheimer's disease. Neuron 2008, 59:190-194.
27. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185.
28. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., Malinow R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 2006, 52:831-843.
29. Huang S.M., Mouri A., Kokubo H., Nakajima R., Suemoto T., Higuchi M., et al. Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. J.Biol. Chem. 2006, 281:17941-17951.
30. Hudry E., Wu H.Y., Arbel-Ornath M., Hashimoto T., Matsouaka R., Fan Z., et al. Inhibition of the NFAT pathway alleviates amyloid β neurotoxicity in a mouse model of Alzheimer's disease. J.Neurosci. 2012, 32:3176-3192.
31. Jan A., Hartley D.M., Lashuel H.A. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research. Nat. Protoc. 2010, 5:1186-1209.
32. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R. APP processing and synaptic function. Neuron 2003, 37:925-937.
33. Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M., Roth G.S., Mattson M.P. Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:6753-6758.
34. 2+ dysregulation in neurons from transgenic mice expressing mutant presenilin 2. Aging Cell 2012, 11:885-893.
35. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6448-6453.
36. 2+]i responses at fertilization: a role for the MAP kinase pathway. Development 2006, 133:4355-4365.
37. Lee S., Zemianek J., Shea T.B. Rapid, reversible impairment of synaptic signaling in cultured cortical neurons by exogenously-applied amyloid-β. J.Alzheimers. Dis. 2013, 35:395-402.
38. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., Ashe K.H. Aspecific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
39. Liu J., Chang L., Roselli F., Almeida O.F., Gao X., Wang X., Yew D.T., Wu Y. Amyloid-β induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors. J.Alzheimers Dis. 2010, 22:541-556.
40. Lourenco M.V., Clarke J.R., Frozza R.L., Bomfim T.R., Forny-Germano L., Batista A.F., et al. TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys. Cell Metab. 2013, 18:831-843.
41. Ma T., Trinh M.A., Wexler A.J., Bourbon C., Gatti E., Pierre P., Cavener D.R., Klann E. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat. Neurosci. 2013, 16:1299-1305.
42. Mairet-Coello G., Courchet J., Pieraut S., Courchet V., Maximov A., Polleux F. The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation. Neuron 2013, 78:94-108.
43. Mattson M.P. ER calcium and Alzheimer's disease: in a state of flux. Sci. Signal 2010, 3:pe10.
44. Minano-Molina A.J., Espana J., Martin E., Barneda-Zahonero B., Fado R., Sole M., et al. Soluble oligomers of amyloid-β peptide disrupt membrane trafficking of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor contributing to early synapse dysfunction. J.Biol. Chem. 2011, 286:27311-27321.
45. Mucke L., Selkoe D.J. Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2012, 2:a006338.
46. Nath S., Agholme L., Kurudenkandy F.R., Granseth B., Marcusson J., Hallbeck M. Spreading of neurodegenerative pathology via neuron-to-neuron transmission of beta-amyloid. J.Neurosci. 2012, 32:8767-8777.
47. Nimmrich V., Grimm C., Draguhn A., Barghorn S., Lehmann A., Schoemaker H., et al. Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J.Neurosci. 2008, 28:788-797.
48. Oules B., Del Prete D., Greco B., Zhang X., Lauritzen I., Sevalle J., et al. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease. J.Neurosci. 2012, 32:11820-11834.
49. 2+ release inducing mitochondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF. Antioxid. Redox Signal 2011, 14:1209-1223.
50. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N.Engl. J. Med. 2010, 362:329-344.
51. Resende R., Ferreiro E., Pereira C., Resende de Oliveira C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 2008, 155:725-737.
52. Ricobaraza A., Cuadrado-Tejedor M., Marco S., Perez-Otano I., Garcia-Osta A. Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 2012, 22:1040-1050.
53. Selkoe D.J. Resolving controversies on the path to Alzheimer's therapeutics. Nat. Med. 2011, 17:1060-1065.
54. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J.Neurosci. 2007, 27:2866-2875.
55. Shankar G.M., Walsh D.M. Alzheimer's disease: synaptic dysfunction and Aβ. Mol. Neurodegener. 2009, 4:48.
56. 2+ handling in excitable cells in health and disease. Pharmacol. Rev. 2011, 63:700-727.
57. 2+ disruptions in young, adult, and aged Alzheimer's disease mice. J.Neurosci. 2006, 26:5180-5189.
58. Supnet C., Grant J., Kong H., Westaway D., Mayne M. Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice. J.Biol. Chem. 2006, 281:38440-38447.
59. Supnet C., Noonan C., Richard K., Bradley J., Mayne M. Up-regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer's disease. J.Neurochem. 2010, 112:356-365.
60. Toescu E.C., Verkhratsky A. The importance of being subtle: small changes in calcium homeostasis control cognitive decline in normal aging. Aging Cell 2007, 6:267-273.
61. Um J.W., Kaufman A.C., Kostylev M., Heiss J.K., Stagi M., Takahashi H., et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 2013, 79:887-902.
62. Verderio C., Coco S., Bacci A., Rossetto O., De Camilli P., Montecucco C., Matteoli M. Tetanus toxin blocks the exocytosis of synaptic vesicles clustered at synapses but not of synaptic vesicles in isolated axons. J.Neurosci. 1999, 19:6723-6732.
63. Villemagne V.L., Burnham S., Bourgeat P., Brown B., Ellis K.A., Salvado O., et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013, 12:357-367.
64. Waters J. The concentration of soluble extracellular amyloid-β protein in acute brain slices from CRND8 mice. PLoS One 2010, 5:e15709.
65. Wu H.Y., Hudry E., Hashimoto T., Kuchibhotla K., Rozkalne A., Fan Z., et al. Amyloid β induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J.Neurosci. 2010, 30:2636-2649.
66. 2+ elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J.Neurosci. 2010, 30:11938-11950.
67. Zhao W.Q., Santini F., Breese R., Ross D., Zhang X.D., Stone D.J., et al. Inhibition of calcineurin-mediated endocytosis and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid β oligomer-induced synaptic disruption. J.Biol. Chem. 2010, 285:7619-7632.